This #RareDiseaseWeek, I am proud to celebrate our many members focused on treating rare diseases and the 40th anniversary of the #OrphanDrugAct which has helped incentivize rare disease R&D. Follow Biocom California for Rare Disease Information & Impact throughout the week.

Thank you U.S. FDA #DHCoE Director Tazbaz for sharing your center's priorities and engaging in a thought-provoking roundtable today. It was a great discussion, and we look forward to advancing #digitalhealth together! Thank you Former Account of Eli Lilly and Company Gateway Labs for hosting us.

Why are drug prices so high? RealClearMarkets Explains: Pharmacy Benefit Managers Are An Unsung Source of High Drug Prices | RealClearMarkets realclearmarkets.com/articles/2023/…

In Newsweek’s The New Era of Life Sciences Report, Joe Panetta explains how the industry has changed over the past three decades and the outlook for continued growth. Read the full interview: bit.ly/3yYAr9F

Today, the life science industry mourns the loss of a dedicated leader. SoCalBio Ahmed Enany’s fierce determination, vision, and dedication to the LA biotech community was legendary. All of us at Biocom California will remember his amazing contributions to the industry.

Excited to follow up my meeting last month with CA Lieutenant Governor in San Diego, continuing the discussion with Biocom California's Board on the importance of the life science industry in California. We were honored to have her and look forward to working together more in the future.

Sometimes the seemingly less significant Supreme Court rulings are the most impactful. Congrats to Geraldine Tyler. #94-year-old grandmother gets big win at Supreme Court foxnews.com/politics/94-ye…

California continues to be the leading innovation hub for the life science industry, and the 2023 Economic Impact Report provides key data on the impact it has on the state and regional economies businesswire.com/news/home/2023…

Today, Biocom California signed memorandums of understanding with two Korean organizations, KIMCo and KPBMA, to promote cooperation in economic relations, trade, and investment between Korea and the US.

Today, the CA life science industry mourns the loss of Senator Dianne Feinstein. Joe Panetta shares, “Her passing marks the loss of one of California's most ardent supporters, and Biocom California extends its heartfelt gratitude for her unwavering dedication to life science.”

We Biocom California and our members extend heartfelt congratulations to John Crowley on his appointment as CEO of #BIO. John, your leadership journey is an inspiration; we are thrilled to embark with you on our shared mission of improving the world through biotechnology.

Get ready for the premier life science partnering event of the year. The Global Life Science Partnering and Investor Conference begins tomorrow. Plan your week in advance by viewing the agenda: bit.ly/45X30T3 #BiocomGPIC

As we kick off #RareDiseaseWeek, I am proud to celebrate Biocom California members focused on treating rare diseases and reaffirm our united commitment to support those affected. Together, we can drive progress and make a meaningful difference.

From California: Today we are at Biocom California's Global Partnering and Investor Conference in La Jolla. Biocom CEO Joseph Panetta talks about the event and the state of California's three major biotech hubs. Full video: biotechtv.com/post/biocom-ca…

Tonight President Biden continued his attacks on our biotechnology industry, proposing to increase drugs under already harmful price controls to 500. These reckless actions not only threaten innovative US drug discovery, they will prevent patient access to life saving drugs.

Our ARPA-H roundtable just started in San Diego with a full house of companies looking to partner and engage with this exciting new agency. Attendees are hearing directly from Director Renee Wegrzyn, Deputy Director, and program managers on best ways to work with the agency.

We’ve wrapped up another successful #BiocomCAFlyIn here in Washington, D.C. Members discussed all things #emergingtech these past two days. Thank you to all the offices who took time out of their day to meet with us!

Great to connect with my old friend Stuart and to establish our Australia connection through MTP Connect yesterday!

Thank you U.S. FDA Director Jeff Shuren for your 15 years of service leading CDRH and for your commitment to improving medical device regulatory processes. It has been an honor to work in collaboration with you all these years.